Turkan Mutlu Yar | Medicine and Dentistry | Research Excellence Award

Assist. Prof. Dr. Turkan Mutlu Yar | Medicine and Dentistry | Research Excellence Award

Ordu University Faculty of Medicine | Turkey

Dr. Turkan Mutlu Yar is a dedicated Doctor Ogretim Uyesi in the Department of Medical Parasitology at Ordu University, Faculty of Medicine, where she has been contributing to academic research, teaching, and diagnostics since 2023. She completed her PhD in Parasitology at İnönü University in 2015, with a thesis focused on the effectiveness of PCR in diagnosing Trichomonas infections in male patients. Her academic background also includes a thesis-based Master’s degree in Parasitology, a non-thesis Master’s degree in Biology Teaching, and a Bachelor’s degree in Biology from Fırat University. Dr. Yar’s research expertise spans intestinal parasites, cystic echinococcosis, trichomoniasis, zoonotic parasitic diseases, diagnostic molecular methods, and machine learning applications in parasitology. She has authored numerous peer-reviewed articles in international journals, including studies on Helicobacter pylori, Toxoplasma gondii, Toxocara species, and intestinal parasite prevalence in clinical and community settings. Her collaborative work also explores the antiparasitic effects of plant extracts, decision tree algorithms for disease severity, and risk factor modeling for parasitic infections. In addition, she has contributed multiple book chapters on parasitic diseases, zoonotic infections, liver trematodes, free-living amoebae, and hospital-acquired parasitic pathogens.

Citation Metrics (Scopus)

4
3
2
1
0

Citations
3

Documents
3

h-index
1

Citations

Documents

h-index

Featured Publications

 

Dujiang Yang | Health Professions | Best Researcher Award

Dr. Dujiang Yang | Health Professions | Best Researcher Award

The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University Spinal Surgery Group | China

Dr. Dujiang Yang is currently pursuing his graduate studies in Traditional Chinese Medicine (Orthopedics and Traumatology) at Southwest Medical University (September 2023–June 2026). Despite being in training, he has already established an exceptionally prolific academic record, demonstrating strong research capability and outstanding scientific productivity. As the first author, he has published 43 English SCI-indexed papers, one Chinese Peking University Core article, several regular English journal papers, and additional Chinese publications. His cumulative SCI impact factor as first author has reached 264.5, reflecting both depth and influence in interdisciplinary biomedical research. His publications span top-tier journals including Annals of the Rheumatic Diseases (IF=20.6), Journal of Extracellular Vesicles (IF=14.5), Advanced Science (IF=14.3), Leukemia (IF=13.4), Cardiovascular Research (IF=13.2), Angiogenesis (IF=9.2), British Journal of Pharmacology (IF=7.7), and many others across fields such as immunology, degenerative diseases, oncology, tissue engineering, and stem cell therapies. His research interests are broad yet cohesive, focusing on molecular mechanisms of disease, regenerative medicine, biomaterials, single-cell analysis, and translational therapeutic strategies. In addition to research articles, he has also contributed multiple commentary papers in SCI journals, including a notable commentary in JAMA Network Open (IF=9.7). Beyond published work, Yang also has several manuscripts under review or accepted, including research utilizing multi-omics approaches, machine learning, network pharmacology, UHPLC-Q-Orbitrap-ESI-MS, and spatial transcriptomics, further demonstrating advanced methodological skills and translational vision. His work—ranging from tendon repair, osteoarthritis treatment, muscle regeneration, virology, to stem cell-based therapy—reflects a rare integration of modern biomedical science with traditional Chinese medicine perspectives. Yang has actively contributed to multiple funded scientific research projects under the supervision of Professor Guoyou Wang. His roles include project design, experimental execution, and manuscript preparation. Key projects include: a National Natural Science Foundation project exploring mechanisms of Shaoyang Shenggu prescription in regulating IL-17/NF-κB pathways to inhibit chondrocyte senescence; and several Sichuan Provincial research grants focused on network pharmacology, TGF-β/GPX4 signaling, iron-death mechanisms, and therapeutic evaluation of traditional herbal approaches in knee osteoarthritis.

Profile: ORCID

Featured Publications

  1. (2025). Navigating the complex landscape of DPP4 inhibition in inflammation: From novel mechanisms to unresolved translational challenges. Inflammation Research.

  2. (2025). USP5-laden ApoEVs and E2F1 stabilization in disc repair: Unresolved questions on senescence, specificity and endosomal escape. Journal of Extracellular Vesicles.

  3. (2025). Advancing the tendinopathy triad: Comment on “Tendinopathy: The interplay between mechanical stress, inflammation, and vascularity”. Advanced Science.

  4. (2025). Time to move beyond treatment initiation: Implementing risk-stratified therapy in fracture liaison services. Osteoporosis International.

 

Aurore Sajust de Bergues de Escalup | Medicine and Dentistry | Research Excellence Award

Mrs. Aurore Sajust de Bergues de Escalup | Medicine and Dentistry | Research Excellence Award

Fondation Adolphe de Rothschild Hospital | France

Dr. Aurore Sajust de Bergues de Escalup is a radiology resident specializing in advanced neuroimaging, thoracic imaging, and musculoskeletal diagnostic modalities, with a growing research portfolio in artificial intelligence–enhanced medical imaging. She is currently completing the advanced phase of her radiology residency at the Hôpital Fondation Adolphe de Rothschild, focusing on neuroradiology and head-and-neck imaging, while simultaneously advancing her research interests in biomedical image analysis and quantitative MRI. Dr. Sajust de Bergues de Escalup holds a Master’s degree in Biomedical Engineering (BioImaging Specialization), awarded with honors, and completed at the PARCC laboratory (Inserm UMR 970). She was awarded the Année Recherche scholarship (ARS), supporting her contributions to translational imaging research. Her academic foundation includes competitive rankings in French national medical examinations (PACES rank: 52; ECN rank: 1227) and early international scientific exposure through her participation in the Biomed Research Academy at the University of Pennsylvania. Her recent peer-reviewed publications reflect an interdisciplinary approach combining clinical expertise and innovation. These include studies on synthetic MRI for optic nerve pathology, deep learning–based MRI reconstruction techniques, and CT phenotypes of interstitial lung disease in autoimmune disorders. Collectively, her work contributes to improving diagnostic accuracy, reducing scan times, and advancing precision imaging in ophthalmologic and thoracic conditions. Her collaborations span multiple major French academic hospitals, including Hôpital Robert-Debré, Hôpital Henri-Mondor, Hôpital Bichat, and the Hôpital de la Timone. Fluent in French and English, she has developed both clinical and research experience across pediatric radiology, emergency imaging, cardiothoracic radiology, and uro-gynecological imaging. Her long-term vision is to contribute to the integration of artificial intelligence and quantitative imaging biomarkers to enhance clinical decision-making and improve patient outcomes in neuroradiology and systemic disease evaluation.

Profile: ORCID

Featured Publications

Sajust de Bergues de Escalup, A., Lecler, A., Poirion, É., Papeix, C., Deschamps, R., Milea, D., Savatovsky, J., Duron, L., & O’Shaughnessy, E. (2025). Deep learning-based image reconstruction significantly improves image quality of MRI examinations of the orbit at 3 Tesla. Diagnostic and Interventional Imaging.

Sajust de Bergues de Escalup, A., Duron, L., Koskas, P., Poirion, É., Papeix, C., Deschamps, R., Milea, D., O’Shaughnessy, E., Savatovsky, J., Fournier, L., et al. (2025). Synthetic MRI for detecting abnormal signals in the optic nerves. Investigative Radiology

Bo Wan | Medicine and Dentistry | Best Researcher Award

Dr. Bo Wan | Medicine and Dentistry | Best Researcher Award

Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China

Dr. Bo Wan is an emerging clinician–scientist in the field of ophthalmology, recognized for his strong commitment to advancing clinical practice and research related to myopia, cataract, and retinal disorders. With several years of experience as an ophthalmologist in a leading medical institution, he has developed extensive competence in the diagnosis, management, and surgical treatment of common and complex ocular diseases. His clinical work is characterized by precision, rigorous reasoning, and patient-centered decision-making, contributing to improved visual outcomes and enhanced quality of life for diverse patient populations. In parallel with his clinical responsibilities, Dr. Wan has maintained an active engagement in academic research, focusing on evidence-based approaches to ophthalmic disorders and exploring strategies for disease prevention and early intervention. He has authored 2 scholarly documents, which together have received 19 citations and an h-index of 1, reflecting the early but growing influence of his research contributions. His work demonstrates a consistent interest in the integration of clinical insights with scientific inquiry, and he has collaborated with colleagues across medical and academic settings to advance shared research goals. These collaborations have supported the development of multidisciplinary perspectives that enrich both clinical practice and investigative rigor. Dr. Wan’s scholarly activities reflect a broader commitment to public health and societal benefit. By contributing to improved diagnostic accuracy and more effective therapeutic pathways in ophthalmology, his work supports long-term visual health and addresses the rising global challenges of myopia and age-related ocular diseases. He is dedicated to continuous professional development and intends to expand his research output, strengthen international collaborations, and contribute to high-impact studies that can influence global ophthalmic guidelines and clinical standards. With a strong foundation in clinical practice, disciplined research habits, and a clear vision for future growth, Dr. Bo Wan is well positioned to make meaningful and sustained contributions to ophthalmic science and global eye health.

Profile: Scopus

Featured Publications

  1. (2024). Parallel comparison of ocular metrics in non-human primates with high myopia by LS900, ultrasonography and MRI-based 3D reconstruction. Experimental Eye Research.

 

Emmanuel Chona | Health Professions | Young Researcher Award

Mr. Emmanuel Chona | Health Professions | Young Researcher Award

Muhimbili University of Health and Allied Sciences, Tanzania

Mr. Emmanuel Z. Chona is a registered nurse, young research scientist, and academic professional with a strong foundation in nursing, public health, and implementation science. He earned his Bachelor of Science in Nursing from the Muhimbili University of Health and Allied Sciences (MUHAS) and is currently pursuing a Master of Public Health in Implementation Science at the same institution under the prestigious EMPOWER-TZ Scholarship by Johns Hopkins University Bloomberg School of Public Health. His professional experience includes serving as an Intern Nurse at Tumbi Regional Referral Hospital, where he gained comprehensive clinical skills in patient care, emergency procedures, and health education, and working as a Tutorial Assistant at St. Joseph University in Tanzania and later at MUHAS, contributing actively to teaching, research, consultancy, and curriculum development. His research interests span oncology nursing, diabetes management, chronic disease care, public health challenges, and disaster preparedness, demonstrated through his 12 peer-reviewed publications (5 as first author) in reputable journals such as PLoS One, BMC Women’s Health, Psycho-Oncology, and Public Health Challenges, with over 202 citations and an h-index of 7, showcasing his scholarly impact. He possesses strong research and technical skills in SPSS, STATA, and NVivo, along with expertise in teaching methodology, communication, and teamwork. His career achievements have been recognized through awards such as the Early Career Research Grant from the Tanzania Diabetes Association, an Excellence Performance Certificate for best undergraduate performance at MUHAS, and the EMPOWER-TZ Master’s Scholarship. Beyond academia, he is actively engaged in professional and community service as a member of the Tanzania National Nurses Association, the International Society of Substance Use Professionals (ISSUP), and a volunteer with the Tanzania Red Cross Society. In conclusion, Emmanuel Chona is an emerging leader in public health and nursing research, combining academic excellence, clinical practice, and impactful research with community service, and he demonstrates strong potential to advance healthcare delivery, mentor future health professionals, and contribute meaningfully to science and society on both national and global scales.

Profile: Scopus | ORCID

Featured Publications

Chona, E. Z., Gosse, R. A., Msengi, E. A., Aruldhas, T. P., Mkonongo, L., Matle, T. M., Iseselo, M. K., & Ambikile, J. S. (2025). Life experiences of women diagnosed with cervical cancer in Sub‐Saharan Africa: A systematic review of qualitative studies. Psycho‐Oncology, 34(1), e70280.

Chona, E. Z., Gosse, R. A., William, D. A., Kiang, R. H., & Ramadham, F. B. (2025). Dietary knowledge and practices among diabetes patients attending Muhimbili National Hospital in Dar es Salaam, Tanzania. Tanzania Journal of Health Research, 26(4), 1–10.

Chona, E. Z., Kayange, L. F., & Iseselo, M. K. (2024b). Factors associated with satisfaction with diabetes care among patients attending public diabetic clinics in Dar es Salaam, Tanzania: A cross-sectional study. Public Health Challenges, 3(3), 1–8.

Chona, E. Z., Kayange, L. F., & Iseselo, M. K. (2024a). Barriers and facilitators to satisfaction with diabetes care: The perspectives of patients attending public diabetic clinics in Dar es Salaam, Tanzania. PLoS One, 19(5), e0302858.

Chona, E. Z., Msengi, E. A., Gosse, R. A., & Ambikile, J. S. (2023). The lived experiences and caring needs of women diagnosed with cervical cancer: A qualitative study in Dar es Salaam, Tanzania. PLoS One, 18(1), e0289925.

Ankit Agrawal | Health Professions | Best Researcher Award

Assist. Prof. Dr. Ankit Agrawal | Health Professions | Best Researcher Award

Post Graduate Institute of Child Health, India

Assist. Prof. Dr. Ankit Agrawal is an accomplished clinician and researcher in Pediatric Gastroenterology and Hepatology with a distinguished academic and professional trajectory marked by consistent excellence and leadership. He completed his MBBS at Peoples College of Medical Science and Research Centre, Bhopal, followed by an MD in Pediatrics  from Gajra-Raja Medical College, Gwalior, and a DM in Pediatric Gastroenterology from Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow. He began his academic career as Assistant Professor at SGPGIMS and is currently serving as Assistant Professor in the Department of Pediatric Gastroenterology at Post Graduate Institute of Child Health, Delhi-NCR, Noida, where he integrates patient care, teaching, and research. His research interests encompass chronic pancreatitis, portal hypertension, pediatric liver diseases, and sustainable innovations in pediatric endoscopy, with a growing body of publications in reputed journals such as Pancreatology, Journal of Clinical and Experimental Hepatology, and Clinical and Experimental Pediatrics, along with contributions to academic books and clinical guidelines. Dr. Agrawal has developed extensive research skills in pediatric endoscopy, including diagnostic UGI endoscopy, colonoscopy, endoscopic band ligation, sclerotherapy, dilatations, polypectomy, and advanced interventional procedures, complemented by training in pediatric hepatology, metabolic liver diseases, and radiological interventions. His academic record includes 111 research documents, 402 citations, and an h-index of 10, reflecting his increasing impact in the field. Recognized internationally, he has received awards such as the First Prize for Best Poster at the Indian Society of Gastroenterology (ISG) Annual Conference (Jaipur, 2023) and the Young Investigator Award for oral presentations at the European Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN, Milan, 2024) and ISG Annual Conference (Varanasi, 2024). With strong professional expertise, collaborative research experience, and a commitment to child health, Dr. Agrawal exemplifies excellence in both academia and clinical practice. His future research and leadership potential lie in advancing global collaborations, increasing high-impact publications, and developing innovative approaches that elevate pediatric gastroenterology standards worldwide, making him highly deserving of recognition for his contributions to research and society.

Profile: Scopus

Featured Publications

Agrawal, A., Gaur, A., & Ambey, R. (2020). Neonatal mid upper arm circumference as surrogate of birth weight. International Journal of Contemporary Pediatrics, 7(3), 491–494.

Agrawal, A., Gaur, A., & Ambey, R. (2020). Newborn mid-upper arm circumference as valid proxy marker of gestational age. Indian Journal of Child Health, 7(2), 54–56.

Agrawal, A. (2024). Urgent need for “green endoscopy” in routine practice in India. Annals of Pediatric Gastroenterology and Hepatology (ISPGHAN).

Agrawal, A., Srivastava, A., Mishra, P., Malik, R., Agrawal, V., Raj, A., Sarma, M. S., Poddar, U., & Bhat, N. K. (2024). Quality of life is impaired in children with chronic pancreatitis: A multicenter study. Pancreatology, 24(6), 817–826.

Agrawal, A., & Sen Sarma, M. (2025). Vomiting: Causes, approach, and cyclical vomiting. In I. Gupta (Ed.), Learning through MCQ in Pediatrics. New Delhi: Jaypee Brothers Medical Publishers Pvt Ltd.

Agrawal, A., Srivastava, A., Moirangthem, A., Singh, S. M., Kodethoor, D., Vadlapudi, S. S., Sarma, M. S., & Poddar, U. (2025). Glycerol-3-Phosphate dehydrogenase 1 deficiency and steatotic liver disease in children: Our cases and review of literature. Journal of Clinical and Experimental Hepatology, 15(3), 102484.

Agrawal, A. (2025). Drugs in pediatric gastroenterology. Annals of Pediatric Gastroenterology and Hepatology, 6(4).

Alexey Fayzullin | Medicine and Dentistry | Pioneer Researcher Award

Dr. Alexey Fayzullin | Medicine and Dentistry | Pioneer Researcher Award

Sechenov University, Russia

Dr. Alexey Fayzullin, PhD, MD, is a distinguished medical scientist specializing in regenerative medicine, computational pathology, and digital biomedical technologies, with a strong academic and research foundation at Sechenov University, Russia. He completed his general medical studies at the International School “Medicine of the Future” (2011–2017) and earned his PhD in anatomical pathology in 2022, with a thesis on antifibrotic scaffolds in regenerative medicine. His professional journey began as a laboratory assistant (2018–2019) and junior researcher (2019–2023) in the Laboratory of Experimental Morphology at the Institute for Regenerative Medicine, before advancing to Head of the Laboratory of Digital Microscopic Analysis in 2023. His research interests span tissue engineering, artificial intelligence in histological image analysis, cell therapy, biophotonics, implantology, and computational biomedicine. With 47 peer-reviewed publications, 626 citations, and an h-index of 12, Dr. Fayzullin has contributed significantly to scientific knowledge, with his works appearing in internationally recognized journals and conferences. His research experience includes prestigious internships at Macquarie University and the University of New South Wales, where he collaborated on advanced bioengineering projects. He has won multiple competitive grants and awards, including several Russian Presidential Scholarships for international research, grants from the Russian Science Foundation (RSF) and Russian Foundation for Basic Research (RFBR), and the establishment of his own laboratory under the Priority 2030 program. His skills include advanced digital microscopy, AI-based image processing, regenerative scaffold design, project leadership, and academic mentoring. As an educator, he has co-authored Russia’s first regenerative medicine handbook, designed specialized academic courses, and supervises PhD and undergraduate students. Dr. Fayzullin’s honors, leadership roles, and international collaborations highlight his impact on both science and education. In conclusion, his remarkable achievements, innovative research, and commitment to biomedical advancement demonstrate why he is an emerging leader with the potential to shape the future of global regenerative medicine and digital healthcare.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Valieva, Y., Ivanova, E., Fayzullin, A., Kurkov, A., & Igrunkova, A. (2022). Senescence-associated β-galactosidase detection in pathology. Diagnostics, 12(10), 2309. Cited 146 times

Shekhter, A. B., Fayzullin, A. L., Vukolova, M. N., Rudenko, T. G., Osipycheva, V. D., & Litvitsky, P. F. (2019). Medical applications of collagen and collagen-based materials. Current Medicinal Chemistry, 26(3), 506–516. Cited 129 times

Deng, W., McKelvey, K. J., Guller, A., Fayzullin, A., Campbell, J. M., Clement, S., & Saunders, C. M. (2020). Application of mitochondrially targeted nanoconstructs to neoadjuvant X-ray-induced photodynamic therapy for rectal cancer. ACS Central Science, 6(5), 715–726. Cited 88 times

Fayzullin, A., Bakulina, A., Mikaelyan, K., Shekhter, A., & Guller, A. (2021). Implantable drug delivery systems and foreign body reaction: Traversing the current clinical landscape. Bioengineering, 8(12), 205. Cited 73 times

Fayzullin, A., Churbanov, S., Ignatieva, N., Zakharkina, O., Tokarev, M., & Shekhter, A. (2021). Local delivery of pirfenidone by PLA implants modifies foreign body reaction and prevents fibrosis. Biomedicines, 9(8), 853. Cited 35

Shekhter, A. B., Pekshev, A. V., Vagapov, A. B., Telpukhov, V. I., Panyushkin, P. V., Fayzullin, A. L., & Vanin, A. F. (2019). Physicochemical parameters of NO-containing gas flow affect wound healing therapy: An experimental study. European Journal of Pharmaceutical Sciences, 128, 193–201. Cited 34

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

AOU San Luigi Gonzaga Orbassano (Torino), Italy

Dr. Giovanni Musso is a renowned clinician and researcher in Internal Medicine with a distinguished academic and professional career. He graduated in Medicine in 1996 with top honors (110/110) and completed his specialization in Internal Medicine in 2002 with distinction. Currently serving at the Department of Internal Medicine, Humanitas Gradenigo Hospital, Turin, he has devoted his career to the study of lipid and glucose metabolism, with particular emphasis on non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD/MASH), and related metabolic complications. He leads international collaborative research involving 34 centers worldwide, producing high-impact findings on NAFLD epidemiology, pathogenesis, and staging, with publications in PLOS Medicine, Hepatology, Gastroenterology, BMJ, and other leading journals. His research interests include lipidomics, postprandial metabolism, gut microbiota, metabolic inflammation, and therapeutic innovations such as curcumin-based interventions and endoscopic approaches for metabolic disorders. His research skills span clinical trials, meta-analyses, translational studies, and consensus guideline development. Recognized globally, Dr. Musso has authored 101 documents, accrued 12,017 citations, and holds an impressive h-index of 49 (Sept 2025). His honors include co-authoring international consensus statements and leading global research collaborations. With his proven excellence in research, teaching, and clinical innovation, Dr. Musso continues to advance the field of hepatology and metabolic medicine while shaping future directions in precision healthcare.

Profile: Scopus | ORCID

Featured Publications

  • Musso, G., Mariano, F., Mella, A., Pinach, S., & Gambino, R. (2025, August 7). Meal-Induced NF-κB Activation in Mononuclear Cells Triggers Lumican Secretion and Promotes Chronic Kidney Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease. MedComm, 6(8), e70122.

  • Carpenito, N., Leporati, M., Sciarrillo, A., Pensa, A., Gambino, R., Musso, G., Mella, A., Biancone, L., Risso, D., Mariano, F., & Cosseddu, D. (2025, May 16). LC-MS/MS Determination of Quorum Sensing Molecules in Plasma from Burn Patients with Septic Shock Sustained by Acinetobacter baumannii. Antibiotics (Basel), 14(5), 517.

  • Musso, G., Mella, A., Mariano, F., Cassader, M., De Michieli, F., Riva, A., Petrangolini, G., Togni, S., Pinach, S., & Gambino, R. (2024). Impaired Postprandial GLP-2 Response Enhances Endotoxemia, Systemic Inflammation, and Kidney Injury in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Effect of Phospholipid Curcumin Meriva. Gut Microbes, 16(1), article 2424907.

  • Musso, G., Pinach, S., Mariano, F., Saba, F., De Michieli, F., Framarin, L., Berrutti, M., Paschetta, E., Parente, R., Lizet Castillo, Y., Leone, N., Castellino, F., Cassader, M., & Gambino, R. (2025, February 1). Effect of Phospholipid Curcumin Meriva® on Liver Histology and Kidney Disease in Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Hepatology, 81(2), 560–575.

  • Musso, G., Pinach, S., Saba, F., De Michieli, F., Cassader, M., & Gambino, R. (2024, July). Endoscopic Duodenal Mucosa Ablation Techniques for Diabetes and Nonalcoholic Fatty Liver Disease

 

Xingwang Yao | Health Professions | Best Researcher Award

Assoc. Prof. Dr. Xingwang Yao | Health Professions | Best Researcher Award

The Second Xiangya Hospital (Central South University, China) | China

Dr. Yao Xingwang is a senior nurse and accomplished clinical researcher at the Operating Department, Xiangya Second Hospital, Central South University, China. With a strong background in clinical nursing, patient care, and interdisciplinary medical research, he has established himself as a leading figure in the integration of nursing practice with scientific innovation. His professional journey reflects dedication to enhancing the quality of healthcare services through advanced nursing strategies, patient-centered interventions, and translational research. Dr. Yao has actively contributed to the development of innovative treatment methods, clinical nursing guidelines, and healthcare technologies that improve patient outcomes in complex medical conditions. He has also played a key role in research projects funded by provincial and institutional bodies, focusing on areas such as cancer therapy, cardiovascular health, chronic disease management, and perioperative nursing care. Beyond clinical practice and research, Dr. Yao has contributed to academic literature through peer-reviewed journal articles, patents, and textbooks. His ability to bridge the gap between evidence-based nursing and real-world clinical application makes him a highly respected professional in his field. Dr. Yao’s leadership, innovation, and scholarly contributions position him as a distinguished candidate for recognition in international research awards.

Professional Profile

Education

Dr. Yao Xingwang pursued his academic journey at Central South University, one of China’s leading institutions in nursing education and medical sciences. He obtained a Bachelor of Science in Nursing, which laid the foundation for his clinical expertise and patient-centered approach in healthcare. Building upon this, he completed his Master of Science in Nursing under the supervision of esteemed faculty, where he deepened his understanding of advanced nursing practices, clinical interventions, and evidence-based care models. Throughout his education, Dr. Yao developed strong research skills, participating in academic projects that explored the intersections of nursing care and biomedical sciences. His postgraduate studies enabled him to contribute to multidisciplinary research teams, enriching his clinical knowledge with a solid research background. His academic foundation not only provided him with technical expertise but also instilled in him the values of professionalism, compassion, and scientific inquiry. This balance of clinical knowledge and academic training shaped him into a professional capable of leading complex nursing projects and conducting impactful clinical studies. His educational background has been the cornerstone of his career success, empowering him to blend theoretical knowledge with practical applications in the advancement of nursing science and patient care.

Professional Experience

Dr. Yao Xingwang has built an extensive professional career at the Operating Department, Xiangya Second Hospital, Central South University, where he has served in various capacities with increasing responsibility. His early experience as a clinical nurse provided him with hands-on expertise in perioperative care, surgical assistance, patient monitoring, and emergency response. Through dedication and continuous professional development, he advanced to the role of senior nurse, where he has been responsible for supervising clinical teams, ensuring adherence to nursing protocols, and implementing high standards of patient safety and care quality. In addition to his clinical responsibilities, Dr. Yao has been deeply engaged in medical research projects, serving as both a principal investigator and key member in studies supported by provincial foundations and health commissions. His professional experience extends to academic contributions, including publishing in high-impact journals and contributing to textbooks on nursing management and clinical practices. He has also been active in developing innovative healthcare devices, holding patents that address practical clinical challenges. Dr. Yao’s career reflects a seamless integration of nursing service, research innovation, and leadership, making him a role model for aspiring nursing professionals and a respected figure in the field of healthcare.

Research Interest

Dr. Yao Xingwang’s research interests lie at the intersection of nursing science, medical innovation, and patient-centered care. His work focuses on clinical nursing quality evaluation, mindfulness-based interventions for patients with chronic conditions, and the development of evidence-based nursing protocols to improve treatment outcomes. He has contributed significantly to research in cancer therapy, investigating the role of autophagy in cancer stem cell treatment and advancing photodynamic therapy strategies. In cardiovascular nursing, his studies have explored the mechanisms of myocardial injury and interventions that can reduce patient mortality and morbidity. Additionally, Dr. Yao has shown keen interest in mental health within nursing practice, leading projects that examine the impact of mindfulness therapy on depression, anxiety, and cognitive function in elderly diabetic patients. His research also extends to the development of clinical tools and devices, with patents addressing surgical and postoperative care needs. A common theme across his research is the integration of advanced biomedical insights with nursing interventions, ensuring that scientific advancements translate into tangible improvements in patient care. Dr. Yao’s research interests not only address pressing healthcare challenges but also reflect a vision of holistic, evidence-based nursing practice with global impact.

Research Skills

Dr. Yao Xingwang possesses a comprehensive set of research skills that complement his clinical expertise and enable him to conduct high-impact studies in nursing and healthcare. He is proficient in clinical trial design, data collection, and statistical analysis, allowing him to evaluate the effectiveness of nursing interventions with precision. His skills in laboratory techniques support his involvement in biomedical research projects, particularly in cancer biology and cardiovascular studies. Dr. Yao is experienced in the use of advanced imaging tools, including magnetic resonance imaging, for clinical research purposes. He is also skilled in qualitative and quantitative research methodologies, enabling him to address both patient experiences and measurable clinical outcomes. Beyond technical skills, Dr. Yao demonstrates strong project management capabilities, having successfully coordinated multidisciplinary research teams and contributed to projects funded by major provincial and institutional bodies. His ability to translate research findings into practical nursing protocols showcases his applied research strength. Furthermore, his editorial and textbook contributions reflect his academic writing and scientific communication skills. Collectively, these skills underscore his capacity to bridge clinical practice with rigorous research, positioning him as a versatile researcher dedicated to improving patient outcomes through evidence-based nursing innovations.

Awards and Honors

Dr. Yao Xingwang has earned recognition through his contributions to nursing research, clinical practice, and innovation. His scholarly achievements include publications in esteemed journals such as the International Journal of Molecular Medicine, FASEB Journal, and Medicine (Baltimore), where his work has advanced understanding in areas of degenerative disease, cancer biology, and clinical interventions. His role as co-first author and corresponding author in several papers highlights his leadership and intellectual contributions to collaborative research. Dr. Yao has also been honored for his innovation in healthcare technologies, holding utility model patents for devices such as adjustable pancreatic juice diversion systems, multifunctional operating bed covers, and specialized drainage devices for cardiac surgery. These patents demonstrate his ability to identify clinical challenges and provide practical, patient-focused solutions. Additionally, his editorial contributions as compiler and deputy editor of nursing and clinical surgery textbooks reflect recognition of his academic expertise and teaching value. These honors underscore his influence in shaping nursing knowledge, advancing clinical practice, and fostering healthcare innovation. Collectively, Dr. Yao’s awards and honors showcase a career defined by excellence, leadership, and impactful contributions to both academic research and clinical nursing practice.

Publication Top Notes

  • FOXO3-Activated circFGFBP1 Inhibits Extracellular Matrix Degradation and Nucleus Pulposus Cell Death via miR-9-5p/BMP2 Axis in Intervertebral Disc Degeneration In Vivo and In Vitro — 2023 — 2 citations

Conclusion

In conclusion, Dr. Yao Xingwang exemplifies the qualities of a distinguished nurse researcher, clinician, and innovator. His career has been marked by an exceptional combination of hands-on nursing excellence, groundbreaking research contributions, and dedication to improving healthcare outcomes. By bridging clinical nursing with advanced biomedical research, he has advanced patient care in oncology, cardiovascular health, chronic disease management, and mental health interventions. His patents and publications stand as evidence of his innovative spirit and scholarly productivity, while his editorial work reflects a commitment to knowledge dissemination and professional education. Dr. Yao’s leadership in clinical projects, combined with his patient-centered approach, highlights his ability to influence both practice and policy within nursing science. With a proven track record of success and a clear vision for future contributions, he is well-positioned to expand his global collaborations, publish in leading international journals, and assume greater leadership roles in the academic and healthcare communities. Dr. Yao’s achievements and potential make him not only deserving of recognition but also an inspiring role model for the next generation of nursing professionals committed to advancing science and society.

Willi Tarver | Medicine and Dentistry | Best Researcher Award

Dr. Willi Tarver | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Ohio State University, United States

Dr. Willi L. Tarver is a distinguished Assistant Professor in the Division of Cancer Prevention and Control at The Ohio State University, where he leverages his interdisciplinary expertise to address disparities in healthcare delivery and cancer outcomes. With a strong foundation in public health informatics, behavioral oncology, and medical library sciences, Dr. Tarver’s research focuses on integrating patient-reported outcomes (PROs), electronic tools, and equity-focused interventions to better engage underserved populations in the cancer care continuum. His professional trajectory includes advanced fellowships in behavioral oncology and medical informatics, and he is actively involved in federally funded research projects. Dr. Tarver is also deeply committed to mentoring students and early-career professionals, especially from underrepresented backgrounds. His scholarly work addresses systemic issues in healthcare access and aims to develop scalable, tech-based strategies to reduce disparities. In addition to research and teaching, he plays key roles in administrative and clinical improvement initiatives within OSU’s Quality Improvement Hub. Dr. Tarver’s growing leadership within national organizations, innovative approach to equitable cancer prevention, and consistent focus on translating research into real-world applications position him as a leader in academic medicine and public health. He is a compelling nominee for the Best Researcher Award.

Professional Profile

Education

Dr. Tarver’s educational background reflects a unique and valuable combination of public health, information science, and communication, which together form the backbone of his interdisciplinary research. He earned his Doctor of Public Health (Dr.P.H.) from the University of Alabama at Birmingham, where he was also a recipient of the prestigious NCI Diversity Supplement under the Cancer Prevention and Control Training Program. Prior to this, he completed dual Master’s degrees in Public Health (MPH) and Library and Information Science (MLIS) at the University of South Florida. His foundational undergraduate training includes a B.A. in Communication from Columbus State University and an A.S. in Pre-Pharmacy from Gordon College. Dr. Tarver further sharpened his expertise through two postdoctoral fellowships: one in Behavioral Oncology at Indiana University and another in Medical Informatics at the VA Medical Center in Indianapolis. These fellowships provided him with advanced training in clinical research, data analytics, and healthcare system improvement. His broad and deep academic background allows him to bridge clinical research, informatics, and patient-centered interventions—a combination that has enabled his innovative work in cancer disparities and technology-enhanced health solutions.

Professional Experience

Dr. Tarver’s professional journey is defined by a blend of academic, clinical, and administrative roles that support his contributions to cancer prevention, health equity, and public health informatics. Currently serving as an Assistant Professor in the Division of Cancer Prevention and Control within the Department of Internal Medicine at The Ohio State University, he has held this role since 2019. Prior to this appointment, he was a postdoctoral and informatics fellow at the Roudebush VA Medical Center and Indiana University–Purdue University Indianapolis. During his time at the VA, Dr. Tarver contributed to the Center for Health Information and Communication, refining his expertise in applying informatics to support equitable healthcare delivery. His professional roles also extend into quality improvement, where he co-led the Health Equity Core at OSU’s Quality Improvement Hub from 2022 to 2024. Dr. Tarver is an active mentor in OSU’s Center for Cancer Health Equity Summer Research Program, guiding underrepresented students in impactful, community-focused projects. In addition, he participates in institutional governance as a member of OSU’s Innovation Council. Across his roles, he has demonstrated consistent leadership, interdisciplinary collaboration, and a deep commitment to improving health outcomes through equitable and data-driven approaches.

Research Interests

Dr. Tarver’s research is driven by a deep commitment to eliminating disparities in cancer prevention and control through the integration of technology, public health, and clinical practice. His primary interest lies in the development and evaluation of patient-centered technologies—particularly electronic patient-reported outcomes (ePRO) tools—to better engage underserved populations and inform health system decision-making. His projects explore how these tools can be tailored to the unique needs of minority communities, improve cancer survivorship planning, and enhance real-time communication between patients and providers. Another major area of interest is health equity, where Dr. Tarver investigates the impact of perceived discrimination, systemic biases, and cultural barriers on cancer care utilization and outcomes. Additionally, he is involved in research that evaluates educational interventions designed to reduce STEM-related biases in high school learning environments. Through his interdisciplinary work, Dr. Tarver aims to generate actionable insights that not only contribute to academic knowledge but also guide policy reforms and clinical practices. His interests span behavioral oncology, implementation science, and medical informatics, positioning him at the forefront of translational research that impacts patient lives while advancing health equity on a systemic scale.

Research Skills

Dr. Tarver possesses a robust skill set in both qualitative and quantitative research methodologies, which he applies to projects at the intersection of health equity, informatics, and cancer prevention. He is highly experienced in designing and analyzing patient-reported outcomes (PROs), particularly within underserved and minority populations. His expertise includes conducting structured interviews, participant observation, and systematic reviews—skills he actively shares as a guest lecturer in OSU’s Public Health Informatics course. Dr. Tarver is also proficient in research related to intervention development and evaluation, including randomized trials and implementation science frameworks. His grant-writing capabilities are demonstrated by his role as Principal Investigator (PI) and Co-Investigator (Co-I) on several federal and institutional research awards. He collaborates across disciplines, including clinical medicine, education, behavioral science, and information systems, to build comprehensive research designs. Additionally, he has applied informatics tools for data visualization, regulatory decision-making, and game-based learning assessments. These skills empower him to execute complex, multilevel projects with real-world applicability and high translational value. His research toolkit is complemented by strong mentorship abilities, fostering new talent and promoting equity-focused research within academic and clinical settings.

Awards and Honors

Dr. Tarver has received multiple prestigious honors that reflect his academic excellence, research promise, and commitment to advancing health equity. He was honored with the Young Investigator Award at the VA Medical Center in Indianapolis, recognizing his early-career contributions to cancer prevention research. His selection for the VA Advanced Fellowship in Medical Informatics further highlights his potential as a leader in data-driven health solutions. As a fellow in Behavioral Oncology at Indiana University, he gained national recognition for his work integrating psychological, behavioral, and technological approaches to patient-centered care. Notably, he was a recipient of the Diversity Supplement from the National Cancer Institute (NCI) through the University of Alabama at Birmingham, affirming his focus on minority health and health disparities. Earlier in his academic journey, he was awarded the ALSTARS Scholarship at the University of South Florida for academic merit and leadership. These accolades not only reflect his dedication to research excellence but also underscore the national recognition he has received for addressing some of the most pressing challenges in health equity, cancer care, and public health education.

Conclusion

In conclusion, Dr. Willi L. Tarver stands out as an exceptionally well-rounded and impactful academic professional whose contributions significantly advance the fields of cancer prevention, public health informatics, and health equity. His ability to bridge research, mentorship, education, and clinical innovation uniquely qualifies him for the Best Researcher Award. Through interdisciplinary training, funded research projects, and active mentorship, Dr. Tarver continues to address real-world health disparities and improve patient outcomes, particularly in underserved communities. His track record as a Principal Investigator and collaborator on diverse research grants highlights his leadership and collaborative capabilities. Moreover, his mentorship of minority students and involvement in institutional quality improvement initiatives reflect a long-term investment in both people and systems. With a growing portfolio of honors, active society memberships, and educational contributions, Dr. Tarver is positioned for continued excellence and recognition in the academic and public health communities. His work exemplifies the values of translational research, social impact, and scientific integrity, making him a deserving and distinguished candidate for the Best Researcher Award.

Publications Top Notes

1. Family structure and risk behaviors: the role of the family meal in assessing likelihood of adolescent risk behaviors
📅 Year: 2014
✍️ Authors: S. Goldfarb, W.L. Tarver, B. Sen
📰 Psychology Research and Behavior Management, pp. 53–66
📈 Citations: 83

2. The use of cancer-specific patient-centered technologies among underserved populations in the United States: systematic review
📅 Year: 2019
✍️ Authors: W.L. Tarver, D.A. Haggstrom
📰 Journal of Medical Internet Research, 21(4), e10256
📈 Citations: 68

3. Growth dynamics of patient-provider internet communication: trend analysis using the Health Information National Trends Survey (2003 to 2013)
📅 Year: 2018
✍️ Authors: W.L. Tarver, T. Menser, B.W. Hesse, T.J. Johnson, E. Beckjord, E.W. Ford, et al.
📰 Journal of Medical Internet Research, 20(3), e109
📈 Citations: 56

4. A systematic review of the association between family meals and adolescent risk outcomes
📅 Year: 2015
✍️ Authors: S.S. Goldfarb, W.L. Tarver, J.L. Locher, J. Preskitt, B. Sen
📰 Journal of Adolescence, 44, pp. 134–149
📈 Citations: 56

5. Exploring disparities and variability in perceptions and self-reported colorectal cancer screening among three ethnic subgroups of US Blacks
📅 Year: 2010
✍️ Authors: C.K. Gwede, C.M. William, K.B. Thomas, W.L. Tarver, G.P. Quinn, et al.
📰 Oncology Nursing Forum, 37(5), 581
📈 Citations: 51

6. A randomized trial to compare a tailored web-based intervention and tailored phone counseling to usual care for increasing colorectal cancer screening
📅 Year: 2018
✍️ Authors: V.L. Champion, S.M. Christy, W. Rakowski, W.G. Gathirua-Mwangi, W.L. Tarver, et al.
📰 Cancer Epidemiology, Biomarkers & Prevention, 27(12), 1433–1441
📈 Citations: 35

7. The impact of health information technology on cancer care across the continuum: a systematic review and meta-analysis
📅 Year: 2016
✍️ Authors: W.L. Tarver, N. Menachemi
📰 Journal of the American Medical Informatics Association, 23(2), 420–427
📈 Citations: 35

8. Perceptions of colorectal cancer among three ethnic subgroups of US blacks: a qualitative study
📅 Year: 2011
✍️ Authors: C.K. Gwede, E. Jean-Francois, G.P. Quinn, S. Wilson, W.L. Tarver, K.B. Thomas, et al.
📰 Journal of the National Medical Association, 103(8), 669–680
📈 Citations: 35

9. Allostatic load: a framework to understand breast cancer outcomes in Black women
📅 Year: 2021
✍️ Authors: S. Obeng-Gyasi, W. Tarver, R.C. Carlos, B.L. Andersen
📰 NPJ Breast Cancer, 7(1), 100
📈 Citations: 34

10. Factors associated with adherence to mammography screening among insured women differ by income levels
📅 Year: 2018
✍️ Authors: W. Gathirua-Mwangi, A. Cohee, W.L. Tarver, A. Marley, E. Biederman, et al.
📰 Women’s Health Issues, 28(5), 462–469
📈 Citations: 34